Century Therapeutics Inc is a biotechnology business based in the US. Century Therapeutics shares (IPSC) are listed on the NASDAQ and all prices are listed in US Dollars. Century Therapeutics employs 170 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Century Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – IPSC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Century Therapeutics stock price (NASDAQ: IPSC)
Use our graph to track the performance of IPSC stocks over time.Century Therapeutics shares at a glance
Latest market close | $8.79 |
---|---|
52-week range | $7.32 - $32.90 |
50-day moving average | $9.32 |
200-day moving average | $14.50 |
Wall St. target price | $25.20 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.57 |
Buy Century Therapeutics shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Century Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Century Therapeutics price performance over time
Historical closes compared with the close of $8.79 from 2022-07-01
1 week (2022-06-24) | -3.19% |
---|---|
1 month (2022-06-03) | 9.33% |
3 months (2022-04-04) | -28.77% |
6 months (2022-01-04) | -42.25% |
1 year (2021-07-02) | -69.96% |
---|---|
2 years (2020-06-30) | N/A |
3 years (2019-06-30) | N/A |
5 years (2017-06-30) | N/A |
Century Therapeutics financials
Revenue TTM | $1.1 million |
---|---|
Gross profit TTM | $0 |
Return on assets TTM | -15.58% |
Return on equity TTM | -36.25% |
Profit margin | 0% |
Book value | $6.72 |
Market capitalisation | $517.3 million |
TTM: trailing 12 months
Century Therapeutics share dividends
We're not expecting Century Therapeutics to pay a dividend over the next 12 months.
You may also wish to consider:
- Pfizer (PFE.US) (3.19% forward annual dividend yield)
Century Therapeutics overview
Century Therapeutics, Inc. , a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania. .
Century Therapeutics in the news
Century Therapeutics Announces Its Addition to the Russell Microcap® Index
Century Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium
Century Therapeutics to Host Virtual Research and Development Day on June 13, 2022
Frequently asked questions
What percentage of Century Therapeutics is owned by insiders or institutions?Currently 36.592% of Century Therapeutics shares are held by insiders and 60.156% by institutions. How many people work for Century Therapeutics?
Latest data suggests 170 work at Century Therapeutics. When does the fiscal year end for Century Therapeutics?
Century Therapeutics's fiscal year ends in December. Where is Century Therapeutics based?
Century Therapeutics's address is: 3675 Market Street, Philadelphia, PA, United States, 19104 What is Century Therapeutics's ISIN number?
Century Therapeutics's international securities identification number is: US15673T1007
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert